SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-23-000031
Filing Date
2023-05-03
Accepted
2023-05-03 16:06:20
Documents
13
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20230503.htm   iXBRL 8-K 45872
2 EX-99.1 mygn-xq123earningsreleasex.htm EX-99.1 316833
  Complete submission text file 0000899923-23-000031.txt   529054

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20230503.xsd EX-101.SCH 1884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20230503_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20230503_pre.xml EX-101.PRE 12496
7 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20230503_htm.xml XML 11754
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 23883688
SIC: 2835 In Vitro & In Vivo Diagnostic Substances